Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details) - Schedule of segment reporting information

v3.21.2
Segment Information (Details) - Schedule of segment reporting information - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Segment Reporting Information [Line Items]        
Other operating expenses $ 2,377,365 $ 3,031,330 $ 4,753,833 $ 6,295,977
Interest expense (46,131) (42,469) (91,280) (84,638)
Other income (expense) (16,499) (11,086) (34,880) (17,506)
Total other expense, net (62,630) (53,555) (126,160) (102,144)
Net loss 2,364,910 3,056,382 4,732,028 6,327,163
Real property operations [Member]        
Segment Reporting Information [Line Items]        
Revenues 280,232 301,267 570,006 598,223
Costs and expenses 205,147 272,764 422,041 527,265
Real property operations 75,085 28,503 147,965 70,958
Other operating expenses 78,830 103,218 180,253 214,034
Other income (expense) 4 4 108 (931)
Net loss 3,741 74,711 32,180 144,007
Medical related consulting services - related party [Member]        
Segment Reporting Information [Line Items]        
Other operating expenses 167,275 175,891 328,828 331,126
Other income (expense) (16,503) (11,091) (34,989) (16,578)
Net loss 183,778 186,982 363,817 347,704
Development services and sales of developed products [Member]        
Segment Reporting Information [Line Items]        
Other operating expenses 30,240 66,239
Other income (expense) 1 3
Net loss 30,239 66,236
Corporate/Other [Member]        
Segment Reporting Information [Line Items]        
Other operating expenses 2,131,260 2,721,981 4,244,752 5,684,578
Interest expense (46,131) (42,469) (91,280) (84,638)
Other income (expense) 1
Net loss $ 2,177,391 $ 2,764,450 $ 4,336,031 $ 5,769,216